Efficacy and Safety of Dacomitinib in the Treatment of Skin Squamous Cell Cancer
Clinical trial NCT02268747 · UNKNOWN
Trial details
- NCT number
- NCT02268747
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2016-11-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.